Compare Byrna Technologies Inc (BYRN) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Byrna Technologies Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Byrna Technologies Inc trades at $4.68 (market cap $106.74M), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 768.8× Byrna Technologies Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Byrna Technologies Inc pays none. Which is the better fit depends on your goals.
| BYRN | REGN | |
|---|---|---|
Market Cap | $106.74M | $82.06B |
Sector | Technology | Health |
52-Week High | $27.63 | $812.27 |
52-Week Low | $3.18 | $555.51 |
Enterprise Value | $98.35M | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Byrna Technologies Inc
Byrna Technologies specializes in less-lethal personal security devices. It develops and manufactures innovative handheld launchers and projectiles designed for self-defense, law enforcement, and private security use.
Read more on BYRN →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
